Defense Advanced Research Projects AgencyTagged Content List

Medical Devices

Relating to non-pharmacologic interventions to diagnose, prevent or treat disease or injury

Showing 75 results for Med-Devices RSS
The Bioelectronics for Tissue Regeneration (BETR) program will develop technology aimed at speeding warfighter recovery, and thus resilience, by directly intervening in wound healing. To do this, researchers will build an adaptive system that uses actuators to biochemically or biophysically stimulate tissue, sensors to track the body’s complex response to that stimulation, and adaptive learning algorithms to integrate sensor data and dictate intervention to the actuators.
The DoD requires timely and comprehensive threat detection to support overall readiness, counter the spread of disease, and promote stabilization missions. State of the art diagnostic and biosurveillance systems are unable to keep pace with disease outbreaks and fail to support decision-making at the time and place of need. The “Detect It with Gene Editing Technologies” (DIGET) program aims to leverage advances in gene editing technologies to develop field-forward diagnostic and biosurveillance technologies that enable detection of any threat, anytime, anywhere.
The Dialysis-Like Therapeutics (DLT) program aims to support force protection and military readiness by improving critical care in low-resource environments and delivering a new tool for rapid response to emerging infectious disease threats. DLT specifically addresses a life-threatening blood infection known as sepsis, but DARPA is working to expand the DLT technology to also mitigate threats from harmful bacteria, viruses, fungi, and toxic agents in the blood.
The Electrical Prescriptions (ElectRx) program aims to support military operational readiness by reducing the time to treatment, logistical challenges, and potential off-target effects associated with traditional medical interventions for a wide range of physical and mental health conditions commonly faced by our warfighters. ElectRx seeks to deliver non-pharmacological treatments for pain, general inflammation, post-traumatic stress, severe anxiety, and trauma that employ precise, closed-loop, non-invasive modulation of the patient’s peripheral nervous system.
The Epigenetic CHaracterization and Observation (ECHO) program aims to diminish the threat posed by weapons of mass destruction (WMD). To do this, the program is building a man-portable device that analyzes an individual’s epigenetic “fingerprint” to potentially reveal a detailed history of that individual’s exposure to WMD or their precursors. DARPA envisions that the same technology could provide rapid diagnostics for troops who may have been exposed to threat agents or who may be suffering from infections, providing a timely signal to apply effective medical countermeasures.